SCHEMBL24810939

SCHEMBL24810939

c1ccc(-c2cc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)nc(-c3ccc4ccc5cccc6ccc3c4c56)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.40
▸ L3MBTL1 Q9Y468 4/20 0.40
▸ ATM Q13315 1/20 0.40
▸ ERBB2 P04626 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ FYN P06241 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ AHR P35869 1/20 0.36
▸ ALDH1A1 P00352 6/20 0.36
▸ HPGD P15428 6/20 0.36
▸ MAPT P10636 5/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ CYP1A1 P04798 1/20 0.35
▸ CYP1B1 Q16678 1/20 0.35
▸ MEN1 O00255 5/20 0.35
▸ KMT2A Q03164 5/20 0.35
▸ NTSR1 P30989 1/20 0.35
▸ LMNA P02545 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17853587 0.91 MAPT (0.40) KDM4EL3MBTL1ATMERBB2CYP1A2
SCHEMBL17853583 0.90 MAPT (0.39) KDM4EL3MBTL1ATMERBB2CYP1A2
SCHEMBL17853584 0.90 DHODH (0.40) KDM4ECYP1A2ALDH1A1HPGDMAPT
SCHEMBL24812007 0.88 KDM4E (0.41) KDM4EL3MBTL1ATMCYP1A2ALDH1A1
SCHEMBL24812017 0.86 KDM4E (0.45) KDM4EL3MBTL1ATMCYP1A2ALDH1A1
SCHEMBL15133322 0.86 KDM4E (0.47) KDM4EL3MBTL1ATMCYP1A2ACHE
SCHEMBL12611876 0.85 KDM4E (0.41) KDM4EL3MBTL1ATMACHEAHR
SCHEMBL14416370 0.85 KDM4E (0.41) KDM4EL3MBTL1ATMCYP1A2ALDH1A1
SCHEMBL19397653 0.85 KDM4E (0.44) KDM4EL3MBTL1ATMCYP1A2ALDH1A1
SCHEMBL24752756 0.85 L3MBTL1 (0.46) KDM4EL3MBTL1ATMCYP1A2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-02-29 — — US disclosed
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 KDM4E 3416/4885L3MBTL1 1876/4885ATM 3436/4885
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE RPS12, TCF12, RRP12 KDM4E 2161/4885L3MBTL1 785/4885ATM 3325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback